Z-1979-2019 Class II Terminated
FDA device recall Z-1979-2019 was initiated by Roche Diagnostics Corporation on Jun 3, 2019 and is designated Class II. Reason for recall: Calibration failures with Std.E, Sens.E, or Dup.E error due to atypical reaction kinetics and quality control failures have occurred due to contamination of R1 reagent with R3 reagent. The recall status is terminated (terminated Aug 28, 2020). Affected quantity: 8 units.
Recall details
- Product Type
- Devices
- Report Date
- Jul 24, 2019
- Initiation Date
- Jun 3, 2019
- Termination Date
- Aug 28, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8 units
Product description
The Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the sample to form an antigen/antibody complex which is measured turbidimetrically.
Reason for recall
Calibration failures with Std.E, Sens.E, or Dup.E error due to atypical reaction kinetics and quality control failures have occurred due to contamination of R1 reagent with R3 reagent.
Distribution pattern
The products were distributed to the following US states: AL, IN, and KY.
Code information
Lot 368756
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1979-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026